|Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer|
T Shree, OC Olson, BT Elie, JC Kester, AL Garfall, K Simpson, ...
Genes & development 25 (23), 2465-2479, 2011
|Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer|
G Iyer, H Al-Ahmadie, N Schultz, AJ Hanrahan, I Ostrovnaya, AV Balar, ...
Journal of Clinical Oncology 31 (25), 3133, 2013
|An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma|
AA Hakimi, H Furberg, EC Zabor, A Jacobsen, N Schultz, G Ciriello, ...
Journal of the National Cancer Institute 105 (24), 1862-1870, 2013
|Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results|
DH Abramson, BP Marr, IJ Dunkel, S Brodie, EC Zabor, SJ Driscoll, ...
British journal of ophthalmology 96 (4), 499-502, 2012
|Genomic characterization of upper tract urothelial carcinoma|
JP Sfakianos, EK Cha, G Iyer, SN Scott, EC Zabor, RH Shah, Q Ren, ...
European urology 68 (6), 970-977, 2015
|Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder|
PH Kim, EK Cha, JP Sfakianos, G Iyer, EC Zabor, SN Scott, I Ostrovnaya, ...
European urology 67 (2), 198-201, 2015
|DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma|
MY Teo, RM Bambury, EC Zabor, E Jordan, H Al-Ahmadie, ME Boyd, ...
Clinical cancer research 23 (14), 3610-3618, 2017
|A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma|
K Kadota, K Suzuki, SS Kachala, EC Zabor, CS Sima, AL Moreira, ...
Modern pathology 25 (8), 1117-1127, 2012
|Body mass index and metastatic renal cell carcinoma: clinical and biological correlations|
L Albiges, AA Hakimi, W Xie, RR McKay, R Simantov, X Lin, JL Lee, ...
Journal of Clinical Oncology 34 (30), 3655, 2016
|Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer|
HA Al-Ahmadie, G Iyer, BH Lee, SN Scott, R Mehra, A Bagrodia, ...
Nature genetics 48 (4), 356-358, 2016
|Impact of smoking and smoking cessation on oncologic outcomes in primary non–muscle-invasive bladder cancer|
M Rink, H Furberg, EC Zabor, E Xylinas, M Babjuk, A Pycha, Y Lotan, ...
European urology 63 (4), 724-732, 2013
|Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy|
M Rink, EC Zabor, H Furberg, E Xylinas, B Ehdaie, G Novara, M Babjuk, ...
European urology 64 (3), 456-464, 2013
|Genetic determinants of cisplatin resistance in patients with advanced germ cell tumors|
A Bagrodia, BH Lee, W Lee, EK Cha, JP Sfakianos, G Iyer, EJ Pietzak, ...
Journal of Clinical Oncology 34 (33), 4000, 2016
|FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma|
K Kadota, C Colovos, K Suzuki, NP Rizk, MPS Dunphy, EC Zabor, ...
Annals of surgical oncology 19 (11), 3598-3605, 2012
|Efficacy of exercise therapy on cardiorespiratory fitness in patients with cancer: a systematic review and meta-analysis|
JM Scott, EC Zabor, E Schwitzer, GJ Koelwyn, SC Adams, TS Nilsen, ...
Journal of Clinical Oncology 36 (22), 2297, 2018
|Myxofibrosarcoma: prevalence and diagnostic value of the “tail sign” on magnetic resonance imaging|
RA Lefkowitz, J Landa, S Hwang, EC Zabor, CS Moskowitz, NP Agaram, ...
Skeletal radiology 42 (6), 809-818, 2013
|Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma|
J Casuscelli, N Weinhold, G Gundem, L Wang, EC Zabor, E Drill, PI Wang, ...
JCI insight 2 (12), 2017
|Dynamic prognostication using conditional survival estimates|
EC Zabor, M Gonen, PB Chapman, KS Panageas
Cancer 119 (20), 3589-3592, 2013
|Guidelines for reporting of statistics for clinical research in urology|
M Assel, D Sjoberg, A Elders, X Wang, D Huo, A Botchway, K Delfino, ...
The Journal of urology 201 (3), 595-604, 2019
|Intra-and interobserver variability in CT measurements in oncology|
A McErlean, DM Panicek, EC Zabor, CS Moskowitz, R Bitar, RJ Motzer, ...
Radiology 269 (2), 451-459, 2013